ELIEM THERAPEUTICS

• 72110 - Research and experimental development on biotechnology

Eliem Therapeutics is developing life-changing therapies for nervous system disorders... Eliem is founded and led by a team of seasoned industry executives who collectively bring decades of clinical development and biopharmaceutical commercialization experience to the company. The team not only shares an unparalleled determination and passion to help patients, but they also have a history of working together to successfully build companies and bring novel and effective therapies to market. Eliem is also advised by a Board with considerable neurology research and development experience and a strong track record of building successful companies... At its core, Eliem is motivated by the promise of helping people live happier, more fulfilling lives. The Eliem team channels its experience, energy and passion for improving patients' quality of life by developing life-changing novel therapies for neuronal excitability disorders based on clinically validated mechanisms of action.

Also known as: Eliem, Eliem Therapeutics (UK) Limited, ELIEM THERAPEUTICS (UK) LTD, Eliem Therapeutics, Inc.

Registration numbers: 11893311 (CH)

Primary location: Wilmington United States